Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim

UK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.

International Business Times

Thousands of women plan legal action over alleged links between talc and cancer

If the action goes ahead it is understood to be the first of its kind against Johnson & Johnson in the UK.

Evening Standard

Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks trading lower: Boeing, Kenvue, ASML, and more are big movers

Here are the stocks making the biggest market moves midday.

The Street

Starboard Value Buys Into Dow Jones Spinoff; ELF Beauty Rallies

Elf Beauty appeared to rally along with KVUE on Monday.

Investors Business Daily

J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook

Johnson & Johnson stock rose Tuesday after the company beat Wall Street's third-quarter expectations, but cut its full-year profit forecast.

Investors Business Daily

3 Highest-yielding Dividend Kings for Maximum Income and Stability

Looking for reliable yield? These three companies offer ever-increasing dividends and a lifetime of stability.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Investors Business Daily

Johnson & Johnson's Q3 2024 Earnings: What to Expect

Johnson & Johnson is all set to announce its third-quarter results this month, and analysts are projecting double-digit earnings decline.

Barchart

Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%

Legend Biotech reversed early gains Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.

Investors Business Daily

Johnson & Johnson Subsidiary Files For Bankruptcy For Third Time

Johnson & Johnson subsidiary files for bankruptcy to settle talc-related cancer lawsuits. Proposed billion settlement faces legal challenges.

Top News

How typography can make or break a brand

We speak to experts in the field of typography to learn how the right type can be the making of a brand — or its undoing.

Creative Bloq

Veteran fund manager views Warren Buffett moves as worrisome

The S&P 500 stock index has climbed 16% year to date.

The Street

3 Healthcare Stocks With Strong Buy Ratings

The healthcare sector is proving to be a robust investment haven, particularly as it continues to evolve with groundbreaking technology and strong government support. Therefore, adding strong A-rated stocks like Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK) could help garner significant returns. Read more….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

'I'm on morphine patches every day': Woman still waiting for vaginal mesh removal four years later

‘I used to walk everywhere, but now I just potter around the house. I no longer walk to the shops,’ June Dunne tells Maya Oppenheim

Barchart

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

Evening Standard

Women harmed by vaginal mesh in England get payout

The amount of the financial settlement has not been made public, although it is expected millions have been paid out

Barchart

This Dividend Aristocrat Just Had Its Best Day Ever After Earnings

This dividend aristocrat crushed Q2 earnings and issued strong guidance, and still has some fuel left in the tank for more growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

140 women win payouts for vaginal mesh complications

Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating

The Guardian - UK

140 women in England receive payout for vaginal mesh implant complications

Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown

Salon

Big Pharma fought to keep prices high

Big Pharma exploited patent laws to stifle competition amid Medicare price negotiations, according to a new report

International Business Times UK

Once Valued At $21B, Avon Files For Bankruptcy Following Lawsuits For 'Cancer-causing' Products

Avon Products Inc. is declaring bankruptcy in the face of numerous lawsuits claiming that the talcum powder in its products causes cancer.

StockNews.com

3 Bargain Healthcare Stocks to Buy for Long-Term Gains

The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for…

Barchart

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

StockNews.com

3 Top Stocks for Dividend Reinvestment Plans (DRIPs)

DRIPs offer a compelling strategy to boost investment returns. This approach helps to compound your gains over time by reinvesting dividends to buy more stock and reducing risk through dollar-cost investing. Top stocks, including Johnson & Johnson (JNJ), Coca-Cola (KO), and PepsiCo (PEP), are ideal for reinvesting dividends to maximize…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.